Mangrove rare actinobacteria: Taxonomy, natural compound and discovery of bioactivity [PDF]
Frontiers in Microbiology, 2015 Actinobacteria are one of the most important and efficient groups of natural metabolite producers. The genus Streptomyces have been recognized as prolific producers of useful natural compounds as they produced more than half of the naturally-occurring ...
Adzzie-Shazleen eAzman +4 more
doaj +8 more sources
Exploring the Potential of Antibiotic Production From Rare Actinobacteria by Whole-Genome Sequencing and Guided MS/MS Analysis [PDF]
Frontiers in Microbiology, 2020 Actinobacteria are well recognized for their production of structurally diverse bioactive secondary metabolites, but the rare actinobacterial genera have been underexploited for such potential. To search for new sources of active compounds, an experiment
Dini Hu +7 more
doaj +8 more sources
Insights on the Effects of Heat Pretreatment, pH, and Calcium Salts on Isolation of Rare Actinobacteria from Karstic Caves [PDF]
Frontiers in Microbiology, 2017 The phylum Actinobacteria is one of the most ubiquitously present bacterial lineages on Earth. In the present study, we try to explore the diversity of cultivable rare Actinobacteria in Sigangli Cave, Yunnan, China by utilizing a combination of different
Bao-Zhu Fang +9 more
doaj +8 more sources
Marine Rare Actinobacteria: Isolation, Characterization, and Strategies for Harnessing Bioactive Compounds [PDF]
Frontiers in Microbiology, 2017 Actinobacteria are prolific producers of thousands of biologically active natural compounds with diverse activities. More than half of these bioactive compounds have been isolated from members belonging to actinobacteria.
Dipesh Dhakal +4 more
doaj +8 more sources
Microbiological and molecular insights on rare Actinobacteria harboring bioactive prospective [PDF]
Bulletin of the National Research Centre, 2020 Background Actinobacteria is as a group of advanced filamentous bacteria. Rare Actinobacteria are of special interest as they are rarely isolated from the environments. They are a major source of important bioactive compounds.
Dina H. Amin +4 more
doaj +4 more sources
Rare actinobacteria isolated from the hypersaline Ojo de Liebre Lagoon as a source of novel bioactive compounds with biotechnological potential [PDF]
Microbiology (United Kingdom), 2022 The Ojo de Liebre Lagoon is a Marine Protected Area that lies within a UNESCO World Heritage Site and is a critical habitat for important migratory species such as the grey whale and bird species. Unique hypersaline environments, such as the Ojo de Liebre Lagoon, are underexplored in terms of their bacterial and chemical diversity, representing a ...
Mónica Torres-Beltrán +2 more
exaly +5 more sources
Rare Actinobacteria and Their Potential Biotechnological Applications [PDF]
مجله علمی دانشگاه علوم پزشکی کردستان, 2022 Background and Aim: Increasing prevalence of nosocomial infections, due to arbitrary use of antibiotics, has caused serious health problems. Natural compounds have been used for many years for the treatment of many infections. Rare actinobacteria are one
hamid abedinlou +3 more
doaj +3 more sources
In silico genomic mining reveals unexplored bioactive potential of rare actinobacteria isolated from Egyptian soil [PDF]
Bulletin of the National Research Centre, 2019 Background Antibiotic resistance occurs rapidly and naturally. However, the misuse of antibiotics is accelerating the process. And therefore, exploring new antibiotics has been a great demand in order to save people’s life.
Dina H. Amin +5 more
doaj +3 more sources
Whole genome sequence and annotation dataset of rare actinobacteria, Barrientosiimonas humi gen. nov., sp. nov. 39T from Antarctica. [PDF]
Data Brief, 2023 Barrientosiimonas humi gen. nov., sp. nov. 39T est une souche rare d'actinobactéries isolée de l'environnement extrême moins exploré du sol antarctique. Ici, nous présentons l'ensemble des données de séquençage et d'annotation du génome provisoire de haute qualité de B. humi de l'Antarctique.
Chong SY, Azmi AA, Cheah YK.
europepmc +5 more sources
Biosynthetic novelty index reveals the metabolic potential of rare actinobacteria isolated from highly oligotrophic sediments. [PDF]
Microb Genom, 2023 Calculations predict that testing of 5 000–10 000 molecules and >1 billion US dollars (£0.8 billion, £1=$1.2) are required for one single drug to come to the market. A solution to this problem is to establish more efficient protocols that reduce the high rate of re-isolation and continuous rediscovery of natural products during early stages of the ...
González-Salazar LA +7 more
europepmc +6 more sources